Marina Blázquez-García

Marina Blázquez-García

Auto-generated profile, based on publicly available information

Marina Blázquez-García

Dept. Analytical Chemistry, Faculty of Chemistry, Universidad Complutense de Madrid, 28040, Madrid, Spain

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2022 in Talanta
Verified
Journal Article
Open access
MBMarina Blázquez-García
Marina Blázquez-García
BABeatriz Arévalo
Beatriz Arévalo
VSVerónica Serafín
Verónica Serafín
SBSara Benedé
Sara Benedé
LMLuis Mata
Luis Mata
SCSusana Campuzano
Susana Campuzano
This work reports the first electrochemical bioplatform for the determination of soy traces in food. The bioplatform involves sandwich-type immunoassays using specific antibodies for β-conglycinin and glycinin, which are the main allergenic soy proteins, and carboxylic acid-modified magnetic microbeads. Amperometric detection at -0.20 V (vs. an Ag pseudo-reference electrode) was performed using single or dual screen-printed carbon electrodes and the H2O2/hydroquinone (HQ) system. The measured variation in the cathodic current was directly proportional to the concentration of target allergenic proteins. The developed bioplatforms exhibit a good selectivity and sensitivity providing limits of detection (LOD) values of 0.03 and 0.02 ng mL-1 for β-conglycinin and glycinin, respectively. The determination of both proteins can be carried out in only 1.5 h. The electrochemical bioplatforms allow their accurate determinations (with results statistically comparable to those provided by ELISA methodologies) in raw cookie dough and baked cookies enriched with soy flour. The results obtained confirm, in a pioneering way with electrochemical biosensors, the possibility of discriminating samples incurred with as little as 0.0005 ppm of a food allergen in model cookie extracts.

22 December 2023 in ChemElectroChem
Verified
Journal Article
Open access
MBMarina Blázquez‐García
Marina Blázquez‐García
Jennifer QuinchiaJennifer Quinchia
Jennifer Quinchia
VMVíctor Ruiz‐Valdepeñas Montiel
Víctor Ruiz‐Valdepeñas Montiel
RTRebeca M. Torrente‐Rodríguez
Rebeca M. Torrente‐Rodríguez
VSVerónica Serafín
Verónica Serafín
SCSusana Campuzano
Susana Campuzano
Tumor‐associated stroma biomarkers are emerging as key signaling molecules of metastasis in colorectal cancer (CRC). In this sense, periostin (POSTN), a protein of the extracellular matrix from the stromal compartment, is envisioned as a potential stromal prognostic biomarker, which facilitates the application of pertinent treatments. In this work, we report an easy‐to‐handle amperometric sandwich‐based immunosensing strategy for the determination of POSTN involving commercial magnetic microparticles (MBs), disposable carbon electrodes, and the horseradish peroxidase (HRP)/H2O2/hydroquinone (HQ) electrochemical system. The method allowed a dynamic linear range between 0.47 and 25 ng mL−1 and a limit of detection, LOD, of 0.14 ng mL−1 compatible with clinical demands. The method was applied to the analysis of POSTN in a variety of cancer‐related real bio‐scenarios including cell extracts and secretomes from CRC cells, and plasma from CRC patients at different stages. The potentials of this firstly developed MBs‐assisted immunoplatform are justified by distinguishing between metastatic abilities of cultured CRC cells through the analysis of their extracts and secretomes, and by differentiating between healthy controls and CRC patients in just 60 min. Therefore, the developed immunoplatform can be envisaged as a novel and profitable tool for exploring the most uncharacterized but prospective tumor areas.

13 December 2022 in Sensors & Diagnostics
Verified
Journal Article
Open access
PDF file
BABeatriz Arévalo
Beatriz Arévalo
MBMarina Blázquez-García
Marina Blázquez-García
AVAlejandro Valverde
Alejandro Valverde
VSVerónica Serafín
Verónica Serafín
PYPaloma Yáñez-Sedeño
Paloma Yáñez-Sedeño
José Manuel PingarrónJosé Manuel Pingarrón
José Manuel Pingarrón
Development and comparison of the first electrochemical bioplatforms for determining anti-centromere B antibodies (CENPB-Abs) developed in magnetic microbead-assisted or integrated formats using His-tag chemistry.

29 February 2024 in Talanta
Verified
Journal Article
Closed access
VMVíctor Ruiz-Valdepeñas Montiel
Víctor Ruiz-Valdepeñas Montiel
MGMaría Gamella
María Gamella
MBMarina Blázquez-García
Marina Blázquez-García
VSVerónica Serafín
Verónica Serafín
EMElena Molina
Elena Molina
SCSusana Campuzano
Susana Campuzano

9 March 2022 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
MBMarina Blázquez-García
Marina Blázquez-García
BABeatriz Arévalo
Beatriz Arévalo
VSVerónica Serafín
Verónica Serafín
SBSara Benedé
Sara Benedé
LMLuis Mata
Luis Mata
SCSusana Campuzano
Susana Campuzano
This work reports the first electrochemical bioplatform for the determination of soy traces in food. The bioplatform involves sandwich-type immunoassays using specific antibodies for β-conglycinin and glycinin, which are the main allergenic soy proteins, and carboxylic acid-modified magnetic microbeads. Amperometric detection at -0.20 V (vs. an Ag pseudo-reference electrode) was performed using single or dual screen-printed carbon electrodes and the H2O2/hydroquinone (HQ) system. The measured variation in the cathodic current was directly proportional to the concentration of target allergenic proteins. The developed bioplatforms exhibit a good selectivity and sensitivity providing limits of detection (LOD) values of 0.03 and 0.02 ng mL-1 for β-conglycinin and glycinin, respectively. The determination of both proteins can be carried out in only 1.5 h. The electrochemical bioplatforms allow their accurate determinations (with results statistically comparable to those provided by ELISA methodologies) in raw cookie dough and baked cookies enriched with soy flour. The results obtained confirm, in a pioneering way with electrochemical biosensors, the possibility of discriminating samples incurred with as little as 0.0005 ppm of a food allergen in model cookie extracts.